GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Replek AD (XMAE:REPL) » Definitions » Accounts Payable

Replek AD (XMAE:REPL) Accounts Payable : MKD307 Mil (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Replek AD Accounts Payable?

Replek AD's Accounts Payable for the quarter that ended in Dec. 2024 was MKD307 Mil.

Replek AD's quarterly Accounts Payable declined from Jun. 2024 (MKD195 Mil) to Sep. 2024 (MKD0 Mil) but then increased from Sep. 2024 (MKD0 Mil) to Dec. 2024 (MKD307 Mil).

Replek AD's annual Accounts Payable declined from Dec. 2022 (MKD263 Mil) to Dec. 2023 (MKD198 Mil) but then increased from Dec. 2023 (MKD198 Mil) to Dec. 2024 (MKD307 Mil).

Replek AD Accounts Payable Historical Data

The historical data trend for Replek AD's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Replek AD Accounts Payable Chart

Replek AD Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 276.73 258.69 263.29 198.49 307.33

Replek AD Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 198.49 194.97 - 307.33

Replek AD Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Replek AD Accounts Payable Related Terms

Thank you for viewing the detailed overview of Replek AD's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Replek AD Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Replek AD (XMAE:REPL) » Definitions » Accounts Payable
Comparable Companies
ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692 SZSE:000538 BOM:500087 ITCI VTRS TSE:4507 NBIX NSE:TORNTPHARM SHSE:688506 BOM:543904 BOM:500124
Traded in Other Exchanges
N/A
Address
Kozle 188, Skopje, MKD
Website
https://www.replek.mk
Replek AD is engaged in the development, design and production of generic medicines. The company develops drugs in different pharmaceutical therapeutic categories including anti-platelet, lipid-lowering, atypical antipsychotic, anti-infective, among others. It manufactures drugs in different forms including tablets, capsules, oral solutions, creams and ointments. Its product portfolio consists of Clopidogrel, Atorvastatin, Simvastatin, risperidone, Clarythromycin, Ciprofloxacin, Meloksikam, Risperidon, terazosin, among others. Replek also offers cannabis oil products, food supplements and cosmetics.